INTRAVENOUS INFUSIONS LIMITED
INTRAVENOUS INFUSIONS LIMITED operates in various business sectors.
INTRAVENOUS INFUSIONS LIMITED (IIL) - Net Assets
Latest net assets as of : GH₵- GHS
Based on the latest financial reports, INTRAVENOUS INFUSIONS LIMITED (IIL) has net assets worth GH₵- GHS as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GH₵-) and total liabilities (GH₵-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GH₵- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
INTRAVENOUS INFUSIONS LIMITED - Net Assets Trend (None–None)
This chart illustrates how INTRAVENOUS INFUSIONS LIMITED's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INTRAVENOUS INFUSIONS LIMITED (None–None)
The table below shows the annual net assets of INTRAVENOUS INFUSIONS LIMITED from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to INTRAVENOUS INFUSIONS LIMITED's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
INTRAVENOUS INFUSIONS LIMITED Competitors by Market Cap
The table below lists competitors of INTRAVENOUS INFUSIONS LIMITED ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Spiritus Mundi PLC
LSE:SPMU
|
$32.69 |
|
BWCCF
PINK:BWCCF
|
$32.79 |
|
CardXX Inc
PINK:CXCQ
|
$32.89 |
|
SUPERIOR RES
BE:3SC
|
$32.95 |
|
Canna 8 Investment Trust
V:RCR-P
|
$32.51 |
|
LIVINGTRUST MORTGAGE BANK PLC
XNSA:LIVINGTRUST
|
$32.46 |
|
Pathos Commun Ltd
LSE:NEWS
|
$32.41 |
|
Iconic Labs Plc
LSE:ICON
|
$32.27 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INTRAVENOUS INFUSIONS LIMITED's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares INTRAVENOUS INFUSIONS LIMITED's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently INTRAVENOUS INFUSIONS LIMITED utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares INTRAVENOUS INFUSIONS LIMITED's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.